Form 3 Protagenic Therapeutics, Inc.\new

3 - Initial statement of beneficial ownership of securities

Published: 2016-03-23 16:38:39
Submitted: 2016-03-23
Period Ending In: 2016-02-12
c84436_3.html


>

SEC FORM 3

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Silverman Joshua

(Last) (First) (Middle)
C/O IROQUOIS CAPITAL MANAGEMENT LLC
205 EAST 42ND ST- 20TH FL

(Street)
NEW YORK NY 10017

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
02/12/2016
3. Issuer Name and Ticker or Trading Symbol
Atrinsic, Inc. [ ATRN ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series B Convertible Preferred Stock 02/12/2016 (2) Common Stock 1,897,468 1.25 I See footnote(1)
Warrants 02/12/2016 02/12/2021 Series B Convertible Preferred Stock 295,945 1.25 I See footnote(1)
Explanation of Responses:
1. Securities being held indirectly through Strategic Bio Partners, LLC of which Iroquois Master Fund Ltd. (the "Fund") and Iroquois Capital Investment Group LLC ("ICIG") are both minority Non-Managing Members (collectively, 49.956%). Mr. Silverman is a member of Iroquois Capital Management L.L.C. who has the shared authority and responsibility for the investments made on behalf of the Fund. Mr. Silverman is a member of ICIG and as such may be deemed to be the beneficial owner of all shares of common stock held by the Fund and ICIG. Mr. Silverman disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
2. Not Applicable.
/s/ Josh Silverman 03/22/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
1
c84436_3.xml
Schema Version:
X0206
Document Type:
3
Period Of Report:
2016-02-12
No Securities Owned:
0

Issuer

Issuer Cik
0001022899
Issuer Name
Atrinsic, Inc.
Issuer Trading Symbol
ATRN

Reporting Owner

Reporting Owner Id

Rpt Owner Cik
0001524858
Rpt Owner Name
Silverman Joshua

Reporting Owner Address

Rpt Owner Street1
C/O IROQUOIS CAPITAL MANAGEMENT LLC
Rpt Owner Street2
205 EAST 42ND ST- 20TH FL
Rpt Owner City
NEW YORK
Rpt Owner State
NY
Rpt Owner Zip Code
10017

Reporting Owner Relationship

Is Director
1
Is Officer
0
Is Ten Percent Owner
0
Is Other
0

Derivative Holding

Security Title
Series B Convertible Preferred Stock
Conversion Or Exercise Price
1.25
Exercise Date
2016-02-12
@attributes Id
F2

Underlying Security

Underlying Security Title
Common Stock
Underlying Security Shares
1897468

Ownership Nature

Direct Or Indirect Ownership
I

Nature Of Ownership

Value
See footnote
@attributes Id
F1
Security Title
Warrants
Conversion Or Exercise Price
1.25
Exercise Date
2016-02-12
Expiration Date
2021-02-12

Underlying Security

Underlying Security Title
Series B Convertible Preferred Stock
Underlying Security Shares
295945

Ownership Nature

Direct Or Indirect Ownership
I

Nature Of Ownership

Value
See footnote
@attributes Id
F1

Footnote

0
Securities being held indirectly through Strategic Bio Partners, LLC of which Iroquois Master Fund Ltd. (the "Fund") and Iroquois Capital Investment Group LLC ("ICIG") are both minority Non-Managing Members (collectively, 49.956%). Mr. Silverman is a member of Iroquois Capital Management L.L.C. who has the shared authority and responsibility for the investments made on behalf of the Fund. Mr. Silverman is a member of ICIG and as such may be deemed to be the beneficial owner of all shares of common stock held by the Fund and ICIG. Mr. Silverman disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
1
Not Applicable.

Owner Signature

Signature Name
/s/ Josh Silverman
Signature Date
2016-03-22
Additional Files
FileSequenceDescriptionTypeSize
0000930413-16-006138.txt   Complete submission text file   6510
$ATRN

© 2019 SEC.report
SEC CFR Title 17 of the Code of Federal Regulations.